Oladimeji Ewumi
Freelance Health Writer at Healthline
Regulatory Medical Writer | CRO | Biopharma & Medical Devices | Bylines @healthline, @medscape, @webmd, @mdlinx, @yuancommunity, @mnt, @everydayhealth
Articles
-
3 weeks ago |
endocrinologyadvisor.com | Oladimeji Ewumi
Early intensive lifestyle intervention (ILS) is most effective in delaying diabetes progression among those with higher baseline HbA1c, whereas metformin treatment effects tend to be greatest among younger patients than older patients, according to study findings published in The Lancet. In studies involving adults at high risk for type 2 diabetes (T2D), evidence supports that behavioral and pharmacological interventions delay or prevent the onset of diabetes for several years.
-
4 weeks ago |
medcentral.com | Oladimeji Ewumi
Subclinical hypothyroidism may be overdiagnosed due to reference ranges not adjusted for factors such as race, sex, and age, according to new data. Published in the Annals of Internal Medicine, the study is the first to use large national datasets to show how individual-level reference intervals impact thyroid disease prevalence estimates.
-
4 weeks ago |
endocrinologyadvisor.com | Oladimeji Ewumi
Independent of diabetes medication, weight gain worsens kidney, glycemic, and cardiovascular outcomes among people with type 2 diabetes (T2D), according to study results published in Diabetes Care. Weight management is a major component of effective T2D management. However, treatment-associated weight gain can interfere with its effectiveness.
-
1 month ago |
rheumatologyadvisor.com | Oladimeji Ewumi
Among older adults with subclinical hypothyroidism (SCH), levothyroxine (LT4) therapy can improve cardiovascular health but increase the risk for osteoporosis, fragility fractures, and all-cause mortality, according to study results published in The Journal of Clinical Endocrinology & Metabolism. Thyroid-stimulating hormone (TSH) levels naturally increase with age.
-
1 month ago |
rheumatologyadvisor.com | Oladimeji Ewumi
Oral antidiabetic drugs (OADs) are more effective than insulin therapy in lowering fracture risk among patients with type 2 diabetes (T2D), according to study results presented at the World Congress on Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases held from April 10 to 13, 2025 in Rome, Italy. T2D medications may impact overall bone integrity and fracture risk.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 158
- Tweets
- 988
- DMs Open
- Yes
I had the privilege of sharing expert insight on the @DeltaDialog podcast about open medical data, emerging AI technologies, and closing healthcare disparity gaps with AI. Always excited to advance these conversations. 😊👌😊 https://t.co/J4aq6kcQ7X
I'm looking to speak with a neurologist for a fast turnaround story I'm working on for Well + Good. My DMs are open. Kindly help retweet or like for more reach. Thank you. #journorequest #medicaljournalist
RT @MillerGeer: Taking Tylenol when hungover can be hard on your liver as it processes the alcohol and Tylenol. Dr. Tanya Dall @ProvCalifor…